28 Healthcare Stocks Moving In Today's Pre-Market Session

Gainers

• T2 Biosystems, Inc. TTOO stock surged 38.1% today to $0.94 during Tuesday's pre-market session. The market cap seems to be at $26.2 million. The most recent rating by Alliance Global Partners, on August 01, is at Neutral, with a price target of $0.40.
• Rockwell Medical, Inc. RMTI stock rose 8.8% today to $2.60. The market cap seems to be at $168.8 million. The most recent rating by Cantor Fitzgerald, on June 25, is at Overweight, with a price target of $11.00.
• CHF Solutions, Inc. CHFS stock surged 8.0% today to $2.70. The market cap stands at $6.1 million.
• Cancer Genetics, Inc. CGIX shares moved upwards by 7.7% today to $0.15. The market cap stands at $8.0 million.
• Aurora Cannabis, Inc. ACB shares surged 6.5% today to $6.59. The market cap seems to be at $5.9 billion. According to the most recent rating by Bank of America, on July 18, the current rating is at Neutral.
• Lexicon Pharmaceuticals, Inc. LXRX stock moved upwards by 6.0% today to $1.41. The market cap stands at $501.0 million. The most recent rating by Citigroup, on July 30, is at Buy, with a price target of $3.00.
• Health Insurance, Inc. HIIQ shares surged 5.9% today to $21.40. The market cap stands at $288.6 million.
• Moleculin Biotech, Inc. MBRX shares increased by 5.9% today to $1.08. The market cap stands at $47.9 million.
• Mallinckrodt, Inc. MNK shares surged 4.2% today to $6.75. The market value of their outstanding shares is at $554.8 million. The most recent rating by Barclays, on June 11, is at Equal-Weight, with a price target of $11.00.
• OPKO Health, Inc. OPK shares moved upwards by 4.1% today to $2.02. The market value of their outstanding shares is at $1.2 billion.
• Arrowhead Pharmaceuticals, Inc. ARWR shares moved upwards by 4.1% today to $28.35. The market cap stands at $2.7 billion. According to the most recent rating by Cantor Fitzgerald, on June 28, the current rating is at Neutral.
• Compugen, Inc. CGEN stock rose 3.6% today to $3.12. The market cap stands at $198.5 million.
• CRISPR Therapeutics, Inc. CRSP stock increased by 3.3% today to $46.50. The market value of their outstanding shares is at $2.8 billion. The most recent rating by Jefferies, on August 01, is at Buy, with a price target of $64.00.
• Cronos Group, Inc. CRON stock surged 2.9% today to $13.81. The market cap stands at $4.2 billion. According to the most recent rating by Consumer Edge, on June 28, the current rating is at Equal-Weight.
• Regeneron Pharmaceuticals, Inc. REGN shares increased by 2.9% today to $308.20. The market cap stands at $33.9 billion. According to the most recent rating by Argus, on June 18, the current rating is at Hold.
• Acorda Therapeutics, Inc. ACOR stock rose 2.7% today to $3.00. The market cap stands at $916.1 million. The most recent rating by Wedbush, on August 02, is at Neutral, with a price target of $7.00.
• Aphria, Inc. APHA shares surged 2.7% today to $7.20. The market value of their outstanding shares is at $1.3 billion. According to the most recent rating by CIBC, on July 26, the current rating is at Underperformer.
• Genfit, Inc. GNFT shares increased by 2.6% today to $16.73. The market value of their outstanding shares is at $689.4 million.
• Amarin Corp, Inc. AMRN stock rose 2.6% today to $17.24. The market cap seems to be at $6.3 billion.
• Cigna, Inc. CI stock rose 2.6% today to $163.06. The market value of their outstanding shares is at $59.7 billion. According to the most recent rating by Bernstein, on August 06, the current rating is at Outperform.
• OrganiGram Holdings, Inc. OGI shares surged 2.5% today to $5.72. The market cap stands at $881.6 million.
• Perrigo Co, Inc. PRGO shares surged 2.2% today to $52.29. The market cap seems to be at $7.1 billion.

Losers

• Leap Therapeutics, Inc. LPTX stock decreased by 6.7% today to $1.94 during Tuesday's pre-market session. The market cap seems to be at $51.6 million.
• SELLAS Life Sciences, Inc. SLS stock declined 4.0% today to $0.18. The market cap stands at $35.4 million.
• Becton, Inc. BDX shares declined 3.5% today to $227.95. The market cap stands at $68.0 billion. The most recent rating by Morgan Stanley, on July 16, is at Equal-Weight, with a price target of $261.00.
• Alnylam Pharmaceuticals, Inc. ALNY shares fell 2.0% today to $70.00. The market value of their outstanding shares is at $8.0 billion. The most recent rating by Goldman Sachs, on May 23, is at Neutral, with a price target of $80.00.
• ViewRay, Inc. VRAY shares plummeted 1.5% today to $7.30. The market value of their outstanding shares is at $855.1 million. The most recent rating by Piper Jaffray, on June 18, is at Overweight, with a price target of $15.00.
• Brainsway, Inc. BWAY stock fell 1.3% today to $9.82. The market cap seems to be at $116.9 million. The most recent rating by Raymond James, on May 13, is at Outperform, with a price target of $14.00.